For all inquiries regarding Tissue Microarrays with survival data, please contact us at support@taibsbio.cn
首页 > 组织芯片 > 乳腺 > FMG08013f
tissue microarray-FMG08013f
  • 点数:
    72
    例数:
    72
    点样直径(mm):
    2
    厚度(µm):
    5
    行数:
    8
    列数:
    9
    组织阵列类型:
    FFPE
    种属:
    Human
FMG08013f
加入收藏

描述: Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FMG08013e

详情: Breast carcinoma with adjacent normal breast tissue microarray, containing 63 cases of invasive carcinoma of no special type, 6 medullary carcinoma, 3 adjacent normal breast tissue, single core per case

应用程序: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

备注

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • 说明书列表
  • 重复病例
  • 下载说明书
图表:
Breast
  • NAT(-)
  • Malignant(-)
  • Malignant(IB)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(IIIA)
  • Malignant(IIIB)
  • _ki
组织芯片
FMG08013f
1
2
3
4
5
6
7
8
9
A
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
B
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
C
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
D
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
E
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
F
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
G
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
H
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
Bre
_ki
FMG08013f
  • 年龄:
  • 性别:
  • 器官/解剖部位:
  • 病理诊断:
  • 等级:
  • 分期:
  • 阶段:
  • 组织ID.:
  • 类型:
位置 No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Ki-67 ER PR Her-2
A1
1 43 F Breast Invasive carcinoma of no special type with necrosis 1 T3N0M0 IIB Malignant - - 0.1 -
A2
2 75 F Breast Invasive carcinoma of no special type 1 T3N1M0 IIIA Malignant - ++90% ++80% -
A3
3 32 F Breast Invasive carcinoma of no special type 1--2 T3N1M0 IIB Malignant +15% +80% ++70% -
A4
4 55 F Breast Invasive carcinoma of no special type 1--2 T4N1M0 IIIB Malignant - - - +30%
A5
5 52 F Breast Invasive carcinoma of no special type 1--2 T2N0M0 IIA Malignant +10% ++80% ++60% +60%
A6
6 54 F Breast Invasive carcinoma of no special type 2 T2N1M0 IIB Malignant - +10% - -
A7
7 48 F Breast Invasive carcinoma of no special type 2 T3N0M0 IIB Malignant - ++20%,+50%,(+) ++70% -
A8
8 30 F Breast Invasive carcinoma of no special type 2 T2N0M0 IIA Malignant +12% +40% +<5%(-) -
A9
9 54 F Breast Invasive carcinoma of no special type (sparse necrosis) 2 T3N0M0 IIB Malignant - - - +40%
B1
10 55 F Breast Invasive carcinoma of no special type 2 T2N2M0 IIIA Malignant - - +<5%(-) ++70%
B2
11 29 F Breast Invasive carcinoma of no special type (sparse) * T2N0M0 IIA Malignant +20% - +5% ++60%
B3
12 87 F Breast Invasive carcinoma of no special type 2 T2N1M0 IIB Malignant - - - -
B4
13 44 F Breast Invasive carcinoma of no special type (sparse) * T2N2M0 IIIA Malignant +10% - +5% ++10%,+20%,(++)
B5
14 42 F Breast Invasive carcinoma of no special type 2 T2N1M0 IIB Malignant +3% - +30% -
B6
15 52 F Breast Invasive carcinoma of no special type 2 T2N1M0 IIB Malignant +6% - +5% -
B7
16 42 F Breast Invasive carcinoma of no special type 2 T4N2M0 IIIB Malignant +20% - - -
B8
17 55 F Breast Invasive carcinoma of no special type 2 T3N2M0 IIIB Malignant +10% +++30%,++50%(+++) +++70% -
B9
18 43 F Breast Invasive carcinoma of no special type 2 T2N1M0 IIB Malignant ++15%,+30%(++) - ++20%,+50%(+) -
C1
19 37 F Breast Invasive carcinoma of no special type 2 T2N1M0 IIb Malignant - - - -
C2
20 38 F Breast Invasive carcinoma of no special type 2 T3N0M0 IIB Malignant ++15%(+) - +20% -
C3
21 48 F Breast Invasive carcinoma of no special type 2 T2N2M0 IIIA Malignant ++80% - ++5%,+60%(+) -
C4
22 37 F Breast Invasive carcinoma of no special type 2 T2N2M0 IIIA Malignant +10% +60% ++65% -
C5
23 48 F Breast Invasive carcinoma of no special type (sparse) * T1N1M0 IB Malignant +8% +55% +60% +10%
C6
24 46 F Breast Invasive carcinoma of no special type 2 T3N2M0 IIIA Malignant +8% - - +++80%
C7
25 68 F Breast Invasive carcinoma of no special type 2 T3N0M0 IIB Malignant - +70% - -
C8
26 51 F Breast Invasive carcinoma of no special type with necrosis 2 T2N2M0 IIIA Malignant +15% +++90% ++40%,+40%(++) -
C9
27 52 F Breast Invasive carcinoma of no special type 2 T4N1M0 IIIB Malignant +5% - +40% +30%
D1
28 52 F Breast Invasive carcinoma of no special type 2 T3N1M0 IIIA Malignant - - - -
D2
29 42 F Breast Invasive carcinoma of no special type 2 T2N0M0 IIA Malignant +20% - +5% -
D3
30 41 F Breast Invasive carcinoma of no special type (sparse necrosis) 2 T2N0M0 IIA Malignant +20% +60% +40% -
D4
31 47 F Breast Invasive carcinoma of no special type 2 T4N1M0 IIIB Malignant +10% ++70% +30% -
D5
32 32 F Breast Invasive carcinoma of no special type with necrosis 2 T4N1M0 IIIB Malignant +25% - - ++80%
D6
33 32 F Breast Invasive carcinoma of no special type 2 T2N1M0 IIB Malignant +10% - +30% ++70%
D7
34 53 F Breast Invasive carcinoma of no special type 2--3 T2N2M0 IIIA Malignant +30% - - -
D8
35 59 F Breast Invasive carcinoma of no special type 2--3 T2N0M0 IIA Malignant +20% - - -
D9
36 38 F Breast Invasive carcinoma of no special type (sparse) * T2N0M0 IIA Malignant - - - *
E1
37 51 F Breast Invasive carcinoma of no special type with necrosis 3 T3N1M0 IIIA Malignant +25% - - +80%
E2
38 58 F Breast Invasive carcinoma of no special type with necrosis 3 T2N1M0 IIA Malignant +40% - - -
E3
39 52 F Breast Invasive carcinoma of no special type 3 T3N2M0 IIIB Malignant - - - +10%
E4
40 48 F Breast Invasive carcinoma of no special type (sparse necrosis) 3 T3N0M0 IIB Malignant ++35% - - +5%
E5
41 55 F Breast Invasive carcinoma of no special type (sparse) 3 T3N0M0 IIB Malignant +10% - - +10%
E6
42 60 F Breast Invasive carcinoma of no special type 3 T2N2M0 IIIA Malignant +40% - +60% +++80%
E7
43 48 F Breast Invasive carcinoma of no special type 3 T4N2M0 IIIB Malignant +30% +++90% +<5%(+) -
E8
44 39 F Breast Invasive carcinoma of no special type 3 T4N2M0 IIIB Malignant ++80% - +80% -
E9
45 61 F Breast Invasive carcinoma of no special type 3 T3N1M0 IIIA Malignant +5% +++60%,++30%(+++) ++10%,+60%(+) -
F1
46 37 F Breast Invasive carcinoma of no special type 3 T3N0M0 IIB Malignant +8% - - -
F2
47 73 F Breast Invasive carcinoma of no special type 3 T4N0M0 IIIB Malignant +20% - - +++80%
F3
48 71 F Breast Invasive carcinoma of no special type 3 T2N1M0 IIB Malignant +18% - +20% +5%
F4
49 44 F Breast Invasive carcinoma of no special type 3 T2N2M0 IIIA Malignant ++30% ++80% +++50%,++40%(+++) ++70%
F5
50 50 F Breast Invasive carcinoma of no special type 3 T2N0M0 IIA Malignant +40% ++40%,+40%(++) - -
F6
51 49 F Breast Invasive carcinoma of no special type 3 T2N2M0 IIIA Malignant +5% +++80% +++20%,++60%(++) -
F7
52 38 F Breast Invasive carcinoma of no special type 3 T2N0M0 IIA Malignant +20% ++30%,+40%(++) ++15%,+40%(+) +10%
F8
53 38 F Breast Invasive carcinoma of no special type (sparse necrosis) 3 T3N1M0 IIIA Malignant +30% - - -
F9
54 50 F Breast Invasive carcinoma of no special type 3 T2N1M0 IIB Malignant ++20% - +60% +20%
G1
55 52 F Breast Invasive carcinoma of no special type 3 T2N0M0 IIA Malignant +8% +35% +20% -
G2
56 54 F Breast Invasive carcinoma of no special type (sparse necrosis) 3 T2N2M0 IIIA Malignant +30% - - -
G3
57 56 F Breast Invasive carcinoma of no special type 3 T2N2M0 IIIA Malignant +10% - - ++80%
G4
58 43 F Breast Invasive carcinoma of no special type 3 T1N1M0 IIA Malignant +5% ++80% +30% -
G5
59 48 F Breast Invasive carcinoma of no special type 3 - - Malignant +5% ++20%,+50%(+) ++85% -
G6
60 40 F Breast Invasive carcinoma of no special type 3 - - Malignant +5% - ++80% -
G7
61 52 F Breast Invasive carcinoma of no special type 3 T1N1M0 IIA Malignant * * * *
G8
62 56 F Breast Invasive carcinoma of no special type 3 T2N2M0 IIIA Malignant +15% ++20%,+40%(+) +++70%,++20%(+++) +++90%
G9
63 43 F Breast Invasive carcinoma of no special type 3 T2N0M0 IIA Malignant +20% +8% +30% -
H1
64 49 F Breast Medullary carcinoma with necrosis - T2N2M0 IIIA Malignant +10% - - -
H2
65 47 F Breast Medullary carcinoma - T2N2M0 IIA Malignant - - - -
H3
66 57 F Breast Medullary carcinoma - T2N1M0 IIB Malignant +10% - - +10%
H4
67 60 F Breast Medullary carcinoma - T3N2M0 IIIB Malignant - - - -
H5
68 59 F Breast Medullary carcinoma - T3N0M0 IIB Malignant - - - +++80%
H6
69 45 F Breast Medullary carcinoma - - - Malignant +5% - - -
H7
70 48 F Breast Adjacent normal breast tissue - - - NAT N+3% N+5% N+8% N-
H8
71 58 F Breast Adjacent normal breast tissue - - - NAT N- N- N++40% N-
H9
72 45 F Breast Adjacent normal breast tissue - - - NAT N- N+5% N++60% N-
_kidney cancera_
查找与该芯片存在重复病例的芯片:
如需了解产品规格方面的任何问题,请联系我们:support@arraysbank.com
0.092369s